-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Ovintiv, Raises Price Target to $55

Benzinga·12/12/2025 21:45:12
Listen to the news
UBS analyst Josh Silverstein maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $54 to $55.